Noticias del mercado

Noticias del mercado

Noticias del mercado financiero argentino e internacional — acciones, bonos, CEDEARs, empresas. Actualizadas al instante.

12/02/2026 ANVS_US — bitget.com
Annovis Bio, Inc. (ANVS) recently announced that its independent Data Safety Monitoring Board (DSMB) has officially approved the company to proceed with the pivotal Phase III clinical trial of Buntanetap for the treatment of Alzheimer's disease.

Annovis Bio, Inc. (ANVS) recently announced that its independent Data Safety Monitoring Board (DSMB) has officially approved the company to proceed with the pivotal Phase III clinical trial of Buntanetap…

Página 6834 de 7483

keyboard_arrow_up